Strong Revenue and Comparable Store Sales Growth
Sales in Q1 rose 5.7% to $510 million with adjusted comparable store sales growth of 5.5%, marking the ninth consecutive quarter of positive growth.
Positive Performance Across All Customer Segments
All three target customer segments (managed care, progressive, and outside Rx) delivered double-digit comps, contributing to overall growth.
Increased Operating Income and EPS
Adjusted operating income rose 21.8% to $41.3 million, and adjusted diluted earnings per share increased to $0.34.
Successful CEO Transition and Strategic Initiatives
CEO succession plans are in place with Alex Wilkes succeeding Reade Fahs as CEO. Strategic initiatives focused on segmentation, personalization, and digitization are proving successful.
Raised Financial Guidance for 2025
Based on strong Q1 results, the company raised its guidance for the year, expecting net revenue between $1.919 billion and $1.955 billion.